(Q56966988)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

[Spanish registry of adverse events of biological therapies in rheumatic diseases (BIOBADASER): report as of january 14, 2005] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Rocío González-González

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

J Gómez-Reino

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

en representación del Grupo de Estudio BIOBADASER

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

95-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1699-258X%2805%2972722-4

7 January 2021

Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report

1 reference

https://api.crossref.org/works/10.1016%2FS1699-258X%2805%2972722-4

7 January 2021

Infection complications associated with the use of biologic agents

1 reference

https://api.crossref.org/works/10.1016%2FS1699-258X%2805%2972722-4

7 January 2021

Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1699-258X%2805%2972722-4

7 January 2021

Infections and anti–tumor necrosis factor α therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1699-258X%2805%2972722-4

7 January 2021

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1699-258X%2805%2972722-4

7 January 2021

10.1016/S1699-258X(05)72722-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21794244%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference